Search Results for "Mrm Proteomics Inc"

04:16 EST 28th January 2015 | BioPortfolio

Original Source: MRM Proteomics Inc.

MRM Proteomics is a leading provider of advanced protein quantification, biomarker and proteomic services to the pharmaceutical, biotechnology and diagnostics industries. We are specialists in quantitative targeted proteomics through the use and development of Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS). Our MRM-MS platform technology has a wide number of applications in drug discovery and clinical development particularly with regards to biomarker discovery/validation, drug t...

Matching Channels

Tumor markers

Tumor markers are substances produced by tumor cells or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. These substances can be found in the blood, in t...

Scotland

With the United Kingdom, Scotland represents a long-standing center of biotechnological excellence, ranked in the top 5 in the world. Over the years, the following important developments have occurr...

Matching News

Race for Proteomics Knowledge Spurs Investment and Partnerships

Proteomics is a focus point for investment and collaboration, according to a new report from Kalorama Information.  The healthcare market research publisher said that over 100 deals had occurred in p...

Novartis and SomaLogic extend proteomics agreement

Novartis has extended its deal with SomaLogic to use the company's proteomics technology for its drug-development efforts.  -More- 

OneOmics Data Environment SWATH Proteomics Cloud Toolkit

AB SCIEX and Illumina have partnered to create what is claimed to be the world’s first multi-omics cloud-computing environment for easy, secure analysis and visualisation of large and complex da...

Applied Proteomics, Inc. Appoints As Chief Financial Officer

SAN DIEGO, Dec. 16, 2014 /PRNewswire/ --Applied Proteomics Inc., the leading developer of protein-based molecular diagnostics, announced today the appointment of Steve R. Martin as chief financial off...

Applying Proteomics to Parkinson’s

Scientists studying two genes that are mutated in an early-onset form of Parkinson’s disease have deciphered how normal versions of these genes collaborate to help rid cells of damaged mitochondria....

Illumina Opens BaseSpace to Proteomics Data

Bio-IT World | The OneOmics Project, a partnership between Illumina and mass spectrometry provider AB SCIEX, has produced a network of apps in the BaseSpace cloud informatics environment to store and ...

Right after Novartis takes stake in proteomics company, it raises $16.5M

Just a few weeks after Novartis announced it’s taken an ownership stake in Colorado’s SomaLogic, the proteomics company has raised $16.5 million, according to a regulatory filing. Althou...

DIA-Umpire: comprehensive computational framework for data-independent acquisition proteomics

The computational workflow of DIA-Umpire allows untargeted peptide identification directly from DIA (data-independent acquisition) proteomics data without dependence on a spectral library for data ext...

Matching PubMed Articles

Cover picture: proteomics 9'14.

The large figure on the cover page has kindly been provided by Dr. Alexandre Zougman, St. James's University Hospital, Leeds, UK (please also see the contribution in this issue: Zougman, A., Selby, P....

"Post-publication notes to J. Proteomics 2012; 75:2433 and J. Proteomics 2012; 75:2443"

Editorial board: Proteomics 3-4'14.

Cover picture: proteomics 3-4'14.

Tissue proteomics and imaging mass spectrometry.

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement